Latest HspE7 Stories
Oropharyngeal cancer patients whose tumors in the upper part of the throat test positively for the human papillomavirus (HPV) have better overall survival than patients with HPV-negative disease.
MONTE CARLO, Monaco, Feb. 18 /PRNewswire-FirstCall/ -- Roche Molecular Systems, Inc.
Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections.
It is estimated that more than 7,000 people are diagnosed with head and neck cancer each year in the UK and approximately 3,500 cases result in death.
Northeastern University scientists in Boston say they have developed an early-stage, highly accurate cancer-screening technology. Professor Max Diem, who developed the the procedure, said it can determine within seconds whether a cell is cancerous, precancerous or normal. The scientists said the technology, for which there is a patent pending, automatically captures a fingerprint of the cell's biochemical composition, which is then analyzed by a computer for abnormalities.
The World Health Organization (WHO) has now approved a new cervical cancer vaccine from pharmaceutical company GlaxoSmithKline.
MEMPHIS, Tenn., Feb. 9 /PRNewswire/ -- Through a new advertising campaign being launched in Memphis today, local women will soon learn more about cervical cancer screening and prevention.
BEDFORD, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Hologic, Inc.
SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an update on its ongoing development programs.
Guided Therapeutics, a medical technology company, has completed its FDA pivotal clinical trial for its LightTouch non-invasive cervical cancer detection device.
- Large; stout; burly.